Back to results
US 12,012,418 B2Granted
Aryl receptor modulators and methods of making and using the same
AssigneeNogra Pharma Limited
InventorsFrancesca Viti, Salvatore Bellinvia, Salvatore Demartis
Life of this patent
Estimating the term…
Abstract
The present invention is generally directed towards compounds capable of binding the aryl hydrocarbon receptor and modulating its activity, methods of treating inflammatory conditions such as Crohn's disease using such compounds, and pharmaceutical compositions comprising such compounds. Also provided are methods of increasing levels of IL-22 in a subject and/or decreasing levels of IFN-γ in a subject.
Claims3
A compound represented by:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.